Soluble CD30 serum level in HCV-positive chronic active hepatitis: A surrogate marker of disease activity?

被引:20
作者
Foschi, FG
Gramenzi, A
Castelli, E
Cursaro, C
Pagani, S
Margotti, M
D'Errico, A
Andreone, P
Stefanini, GF
Bernardi, M
机构
[1] Univ Bologna, Dipartimento Med Interna Cardionagiol Epatol, Serv Semeiot Med, I-40138 Bologna, Italy
[2] Univ Bologna, Ist Anat Patol, Bologna, Italy
[3] Osped Faenza, Div Med Interna, Ravenna, Italy
关键词
CD30; chronic hepatitis; hepatitis C virus; lymphocytes; Th-1; Th-2; response;
D O I
10.1006/cyto.1999.0653
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the present study, high levels of CD30s, a glycoprotein preferentially expressed and released by T lymphocytes producing Th-2-type cytokines, were seen in the sera of patients with chronic hepatitis C, and a correlation with histological activity of the disease was found. CD30s levels were assayed in the sera of 29 HCV RNA-positive patients with histologically proven chronic active hepatitis and in 30 healthy blood donors, Thirteen of 29 (45%) HCV patients had CD30s serum levels above the normal range (>20 U/ml), Mean CD30s serum levels were significantly higher in HCV patients than in controls (P<0.0005). A positive correlation was found between serum CD30s levels and both the histological activity index (r=0.59, P=0.001) and ALT serum levels (r=0.5; P=0.006). The raised CD30s level found in more severe HCV liver disease indirectly suggests activation and expansion of Th-2 cells. CD30s levels could represent a useful surrogate marker of activity in chronic HCV infections. (C) 2000 Academic Press.
引用
收藏
页码:815 / 818
页数:4
相关论文
共 15 条
[1]   CD30, TH2 CYTOKINES AND HIV-INFECTION - A COMPLEX AND FASCINATING LINK [J].
DELPRETE, G ;
MAGGI, E ;
PIZZOLO, G ;
ROMAGNANI, S .
IMMUNOLOGY TODAY, 1995, 16 (02) :76-80
[2]   PREFERENTIAL EXPRESSION OF CD30 BY HUMAN CD4(+) T-CELLS PRODUCING TH2-TYPE CYTOKINES [J].
DELPRETE, G ;
DECARLI, M ;
ALMERIGOGNA, F ;
DANIEL, CK ;
DELIOS, MM ;
ZANCUOGHI, G ;
VINANTE, F ;
PIZZOLO, G ;
ROMAGNANI, S .
FASEB JOURNAL, 1995, 9 (01) :81-86
[3]  
DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629
[4]   Serum levels of soluble CD30 in chronic hepatitis B virus infection [J].
Fattovich, G ;
Vinante, F ;
Giustina, G ;
Morosato, L ;
Alberti, A ;
Ruol, A ;
Pizzolo, G .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 103 (01) :105-110
[5]  
GRUSS HJ, 1994, BLOOD, V83, P2045
[6]  
HAMMAN D, 1996, J IMMUNOL, V156, P1387
[7]   COMPARTMENTALIZATION OF T-LYMPHOCYTES TO THE SITE OF DISEASE - INTRAHEPATIC CD4+ T-CELLS SPECIFIC FOR THE PROTEIN-NS4 OF HEPATITIS-C VIRUS IN PATIENTS WITH CHRONIC HEPATITIS-C [J].
MINUTELLO, MA ;
PILERI, P ;
UNUTMAZ, D ;
CENSINI, S ;
KUO, G ;
HOUGHTON, M ;
BRUNETTO, MR ;
BONINO, F ;
ABRIGNANI, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (01) :17-25
[8]   Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response [J].
Missale, G ;
Bertoni, R ;
Lamonaca, V ;
Valli, A ;
Massari, M ;
Mori, C ;
Rumi, MG ;
Houghton, M ;
Fiaccadori, F ;
Ferrari, C .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (03) :706-714
[9]  
Napoli J, 1996, HEPATOLOGY, V24, P759
[10]  
NELSON DR, 1996, VIRAL HEPATITIS REV, V2, P37